Ignite Creation Date:
2025-12-25 @ 4:28 AM
Ignite Modification Date:
2026-03-10 @ 7:23 PM
Study NCT ID:
NCT06702020
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-11-22
First Post:
2024-11-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
VIS Opti-K Vision Improvement for Presbyopes
Sponsor:
VIS, Inc.
Organization:
Study Overview
Official Title:
VIS Opti-K Vision Improvement for Presbyopes
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
VIS Opti-K 002
Brief Summary:
The VIS Opti-K device and procedure were used to provide vision improvement to patients with presbyopia.
Detailed Description:
The VIS Opti-K device was used to irradiate the cornea with light that changed corneal shape.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?: